Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
文献类型：期刊论文
| 作者 | Villanueva, Alberto; Santamaria, David; Barbacid, Mariano; Nadal, Ernest; Crosetto, Nicola; Ambrogio, Chiara; Gomez-Lopez, Gonzalo; Falcone, Mattia; Vidal, August; Ding, Ke |
| 刊名 | NATURE MEDICINE
 |
| 出版日期 | 2016 |
| 卷号 | 22期号:3页码:270-277 |
| ISSN号 | 1078-8956 |
| 学科主题 | Biochemistry & Molecular Biology ; Cell Biology ; Research & Experimental Medicine |
| 语种 | 英语 |
| 源URL | [http://ir.foo.ac.cn/handle/2SETSVCV/538]  |
| 专题 | 中国科学院广州生物医药与健康研究院 |
| 推荐引用方式 GB/T 7714 | Villanueva, Alberto,Santamaria, David,Barbacid, Mariano,et al. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma[J]. NATURE MEDICINE,2016,22(3):270-277. |
| APA | Villanueva, Alberto.,Santamaria, David.,Barbacid, Mariano.,Nadal, Ernest.,Crosetto, Nicola.,...&Blasco, Rafael B..(2016).Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.NATURE MEDICINE,22(3),270-277. |
| MLA | Villanueva, Alberto,et al."Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma".NATURE MEDICINE 22.3(2016):270-277. |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。